Department of Cell Therapy in Regenerative Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
BOE Regenerative Medicine Technology Co., Ltd., No. 9 JiuXianQiao North Road, Beijing, 100015, China.
Stem Cell Res Ther. 2023 Apr 25;14(1):102. doi: 10.1186/s13287-023-03322-7.
Tissue engineering combines cell biology and material science to construct tissues or organs for disease modeling, drug testing, and regenerative medicine. The cell sheet is a newly developed tissue engineering technology that has brought about scaffold-free tissue and shows great application potential. In this review, we summarized recent progress and future possibilities in preclinical research into and clinical applications of cell sheets fabricated by differing cell types from various sources for cardiac tissue repair, and the manufacturing strategies and promising application potential of 3D cell-dense tissue constructed from cell sheets. Special attention was paid to the mechanisms of mesenchymal stem cell (MSC) sheets in the prevention of myocardial ischemia and left ventricle remodeling. Comparing MSCs sheets with other types of cell sheets and 3D cardiac tissues, engineering tissues' potential safety and effectiveness concerns were also discussed.
组织工程结合细胞生物学和材料科学,构建用于疾病建模、药物测试和再生医学的组织或器官。细胞片层是一种新开发的组织工程技术,它带来了无支架组织,并显示出巨大的应用潜力。在这篇综述中,我们总结了不同来源的不同细胞类型制造的细胞片层在心脏组织修复的临床前研究和临床应用中的最新进展和未来可能性,以及由细胞片层构建的 3D 细胞密集组织的制造策略和有前途的应用潜力。特别关注间充质干细胞(MSC)片层在预防心肌缺血和左心室重构中的机制。将 MSC 片层与其他类型的细胞片层和 3D 心脏组织进行比较,还讨论了工程组织的潜在安全性和有效性问题。